These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5468246)

  • 21. Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man.
    Streeten DH; Anderson GH; Dalakos TG; Seeley D; Mallov JS; Eusebio R; Sunderlin FS; Badawy SZ; King RB
    Endocr Rev; 1984; 5(3):371-94. PubMed ID: 6088218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cushing's syndrome: a prospective study of diagnostic methods.
    Eddy RL; Jones AL; Gilliland PF; Ibarra JD; Thompson JQ; MacMurry JF
    Am J Med; 1973 Nov; 55(5):621-30. PubMed ID: 4749204
    [No Abstract]   [Full Text] [Related]  

  • 23. [Steroid-induced adrenal gland hypofunction. Pathogenesis, clinical aspects, diagnosis, prevention and therapy].
    Bethge H
    Klin Wochenschr; 1970 Mar; 48(6):317-32. PubMed ID: 4329164
    [No Abstract]   [Full Text] [Related]  

  • 24. [Oligosymptomatic hypercortisolism].
    Kandrác MS
    Cas Lek Cesk; 1972 Jul; 111(3):719-24. PubMed ID: 5078986
    [No Abstract]   [Full Text] [Related]  

  • 25. Corticotrophin secretion capacity in multiple sclerosis.
    Rinne UK
    Eur Neurol; 1968; 1(4):221-33. PubMed ID: 4301627
    [No Abstract]   [Full Text] [Related]  

  • 26. DETERMINATIONS OF URINARY 17-HYDROXYCORTICOSTEROIDS AND THEIR RELATION TO CORTISOL SECRETION.
    JAMES VH; CAIE E
    J Clin Endocrinol Metab; 1964 Feb; 24():180-6. PubMed ID: 14123842
    [No Abstract]   [Full Text] [Related]  

  • 27. Laboratory investigation of the human hypothalamic-pituitary-adrenocortical system.
    Grant JK; Hall PE
    Scott Med J; 1971 Feb; 16(2):157-67. PubMed ID: 4324744
    [No Abstract]   [Full Text] [Related]  

  • 28. [Testing of the hypophyseal-adrenal cortex activity with metopirone in adipositas simplex].
    Herbinger W
    Wien Med Wochenschr; 1966 Jun; 116(25):565-7. PubMed ID: 5995247
    [No Abstract]   [Full Text] [Related]  

  • 29. Lack of responsiveness to L-dopa in Cushing's disease.
    Krieger DT
    J Clin Endocrinol Metab; 1973 Feb; 36(2):277-84. PubMed ID: 4345691
    [No Abstract]   [Full Text] [Related]  

  • 30. Failure of metyrapone to inhibit 11-hydroxylation of 11-deoxycortisol during drug therapy.
    Werk EE; Thrasher K; Choi Y; Sholiton LJ
    J Clin Endocrinol Metab; 1967 Sep; 27(9):1358-60. PubMed ID: 4292251
    [No Abstract]   [Full Text] [Related]  

  • 31. Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis.
    Burke CW; Beardwell CG
    Q J Med; 1973 Jan; 42(165):175-204. PubMed ID: 4688791
    [No Abstract]   [Full Text] [Related]  

  • 32. Pitfalls of functional tests for the establishment of the etiology of Cushing's syndrome in childhood and adolescence.
    Rivarola MA; Mendilaharzu H; Dahl V; Heinrich JJ; Spada RP; Mora H; Bergadá C; Cullen M
    J Clin Endocrinol Metab; 1970 Sep; 31(3):254-9. PubMed ID: 4318200
    [No Abstract]   [Full Text] [Related]  

  • 33. [The use of modified stimulation test in the diagnosis of adrenal cortex diseases].
    Konopka P; Morawek A; Religa Z
    Pol Arch Med Wewn; 1969 Jul; 43(1):1025-34. PubMed ID: 4310037
    [No Abstract]   [Full Text] [Related]  

  • 34. Gaschromatographic determination of steroids in the urine of patients with Cushing's syndrome.
    Moolenaar AJ; van Seters AP
    Acta Endocrinol (Copenh); 1971 Jun; 67(2):303-15. PubMed ID: 5108490
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diagnostic informative value of the method of competitive transcortin binding for determining corticosteroid levels in hypercorticism].
    Buniatian AF; Mel'nichenko GA; Ignatenko LL
    Probl Endokrinol (Mosk); 1985; 31(4):24-7. PubMed ID: 4048092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Present state of the dynamic studies of the adrenal cortex (excepting and aldosterone function)].
    Bricaire H; Leprat J; Luton JP
    Presse Med (1893); 1968 Nov; 76(45):2157-60. PubMed ID: 4305257
    [No Abstract]   [Full Text] [Related]  

  • 37. Prolonged hypothalamic-pituitary-adrenal axis activation after acute coronary syndrome in the GENESIS-PRAXY cohort.
    Tang AR; Rabi DM; Lavoie KL; Bacon SL; Pilote L; Kline GA
    Eur J Prev Cardiol; 2018 Jan; 25(1):65-72. PubMed ID: 28969495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cushing's disease without hypercortisolism.
    Dexter RN; Orth DN; Abe K; Nicholson WE; Liddle GW
    J Clin Endocrinol Metab; 1970 May; 30(5):573-9. PubMed ID: 4315478
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chemical determination of adrenal cortex steroids and its significance for the medical diagnosis].
    Stahl F; Dörner G
    Z Gesamte Inn Med; 1968 Mar; 23(6):161-5. PubMed ID: 4882343
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of the hypothalamic-pituitary-adrenocortical axis in chronic leukaemia.
    Migdalska B; Leszko B; Hartwig W; Pawelski S
    Haematologia (Budap); 1976; 10(2):235-42. PubMed ID: 1071742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.